World-first blood test offers profound insight into blood cancer treatment - National
Publish Date: 18/3/2017
With the potential to herald an end to painful and invasive biopsies, a world-first liquid biopsy has been developed by Leukaemia Foundation-funded researchers Prof. Mark Dawson and A/Prof. Sarah-Jane Dawson. This breakthough blood test will allow more effective and personalised treatments
One woman’s remarkable resolve to help give better treatment options for people with rare blood cancers - National
Publish Date: 2/3/2017
A better treatment option for people with the blood cancer myeloproliferative neoplasms (MPN), is one step closer to being made available to Australians, with the new drug interferon alfa-2a (Pegasys®), being discussed at today’s Pharmaceutical Benefits Advisory Committee (PBAC) meeting.
Breakthrough cancer drug venetoclax approved for use in Australia - National
Publish Date: 10/1/2017
New anti-cancer drug, venetoclax which has the power to ‘melt away’ advanced forms of chronic lymphocytic leukaemia (CLL) was recently granted approval by the Australian Therapeutic Goods Administration (TGA).